Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

98 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Seven-year follow-up for energy/vitality outcomes in early stage Hodgkin's disease patients treated with subtotal lymphoid irradiation versus chemotherapy plus radiation: SWOG S9133 and its QOL companion study, S9208.
Moinpour CM, Unger JM, Ganz PA, Kornblith AB, Gaynor ER, Bowers MA, Gatti GS, Kaminski MS, Erba HP, Wang T, Yoon J, Press OW, Fisher RI. Moinpour CM, et al. Among authors: kornblith ab. J Cancer Surviv. 2017 Feb;11(1):32-40. doi: 10.1007/s11764-016-0559-y. Epub 2016 Jul 12. J Cancer Surviv. 2017. PMID: 27405732 Free PMC article. Clinical Trial.
Funding patient-reported outcomes in cancer clinical trials.
Moinpour CM, Denicoff AM, Bruner DW, Kornblith AB, Land SR, O'Mara A, Trimble E. Moinpour CM, et al. Among authors: kornblith ab. J Clin Oncol. 2007 Nov 10;25(32):5100-5. doi: 10.1200/JCO.2007.11.5329. J Clin Oncol. 2007. PMID: 17991928 Review.
Pregnancy outcome in survivors of advanced Hodgkin disease.
Janov AJ, Anderson J, Cella DF, Zuckerman E, Kornblith AB, Holland JC, Kantor AF, Li FP, Henderson E, Weiss RB, et al. Janov AJ, et al. Among authors: kornblith ab. Cancer. 1992 Aug 1;70(3):688-92. doi: 10.1002/1097-0142(19920801)70:3<688::aid-cncr2820700325>3.0.co;2-v. Cancer. 1992. PMID: 1623485
Quality of life among patients with Stage II and III breast carcinoma randomized to receive high-dose chemotherapy with autologous bone marrow support or intermediate-dose chemotherapy: results from Cancer and Leukemia Group B 9066.
Peppercorn J, Herndon J 2nd, Kornblith AB, Peters W, Ahles T, Vredenburgh J, Schwartz G, Shpall E, Hurd DD, Holland J, Winer E. Peppercorn J, et al. Among authors: kornblith ab. Cancer. 2005 Oct 15;104(8):1580-9. doi: 10.1002/cncr.21363. Cancer. 2005. PMID: 16118805 Free article. Clinical Trial.
Issues and challenges with integrating patient-reported outcomes in clinical trials supported by the National Cancer Institute-sponsored clinical trials networks.
Bruner DW, Bryan CJ, Aaronson N, Blackmore CC, Brundage M, Cella D, Ganz PA, Gotay C, Hinds PS, Kornblith AB, Movsas B, Sloan J, Wenzel L, Whalen G; National Cancer Institute. Bruner DW, et al. Among authors: kornblith ab. J Clin Oncol. 2007 Nov 10;25(32):5051-7. doi: 10.1200/JCO.2007.11.3324. J Clin Oncol. 2007. PMID: 17991920 Free PMC article. Review.
Cognitive function in older women with breast cancer treated with standard chemotherapy and capecitabine on Cancer and Leukemia Group B 49907.
Freedman RA, Pitcher B, Keating NL, Ballman KV, Mandelblatt J, Kornblith AB, Kimmick GG, Hurria A, Winer EP, Hudis CA, Cohen HJ, Muss HB; Alliance for Clinical Trials in Oncology. Freedman RA, et al. Among authors: kornblith ab. Breast Cancer Res Treat. 2013 Jun;139(2):607-16. doi: 10.1007/s10549-013-2562-6. Epub 2013 May 17. Breast Cancer Res Treat. 2013. PMID: 23681403 Free PMC article.
98 results